Last updated on April 16, 2014 at 5:49 EDT

Latest E-58425 Stories

2013-10-16 04:21:51

BARCELONA, Spain, October 16, 2013 /PRNewswire/ -- - The results of the study, in patients with acute postoperative moderate to severe pain, show that E-58425 demonstrated superior efficacy and safety over both placebo and a standard of care - E-58425 is a novel, first-in-class, patented, co-crystal product entity - The positive phase II data confirm the Product Concept of E-58425: Clinically relevant and robust pain...